Table 1. – Baseline demographic and clinical characteristics.
| Females (n=321) | Males (n=1,035) | p-value | |
|---|---|---|---|
| Age, years | 68.0±3.0 | 63.3±3.0 | <0.01 |
| BMI, kg/m2 | 22.3±1.9 | 23.0±2.0 | <0.01 |
| Smoking history | 89 (27.7%) | 595 (57.5%) | <0.01 |
| Hypertension | 213 (66.4%) | 479 (46.3%) | <0.01 |
| Diabetes | 79 (24.6%) | 270 (26.1%) | 0.61 |
| Peripheral artery disease | 36 (11.2%) | 155 (15.0%) | 0.10 |
| Cerebrovascular disease | 35 (10.9%) | 59 (5.7%) | <0.01 |
| Syntax score >32 | 142(44.2%) | 376 (36.3%) | 0.01 |
| NYHA class | 0.70 | ||
| I-II | 181 (56.4%) | 569 (55.0%) | |
| III-IV | 140 (43.6%) | 466 (45.0%) | |
| Ejection fraction≥55% | 244 (76.0%) | 801 (77.4%) | 0.60 |
| Lack of myocardial viability | 20 (6.2%) | 46 (4.4%) | 0.23 |
IBMI: body mass index; Syntax: synergy between percutaneous coronary intervention with taxus and cardiac surgery; NYHA: New York Heart Association.